[nd.gov - The Official Portal for North Dakota State Government ]
[North Dakota: Legendary. Follow the trail of legends]
 

Dr. Eric Johnson Column

 

 

 Eric L. Johnson, M.D., is a member of the Dakota Diabetes Coalition. He serves as Assistant Medical Director at Altru Diabetes Center and is an Assistant Professor in the Department of Family and Community Medicine at the University of North Dakota School of Medicine and Health Sciences.

 

If you have comments or questions for Dr. Johnson to address in future columns, please contact Tera Miller at teramiller@nd.gov.
 

GLP-1, DPP-IV's and Pancreatic Disease (#112 - 4/23/2013)

Posted 4/23/13 (Tue) read more »

American Diabetes Association Releases New Diabetes Costs Data (#111 - 3/15/2013)

Posted 3/14/13 (Thu) read more »

New Changes to ADA's Clinical Practice Recommendations (#110 - 2/15/2013)

Posted 2/14/13 (Thu) read more »

Maximizing Pump (CSII) and Sensor (CGMS) Performance (#109 - 1/18/2013)

Posted 1/18/13 (Fri) read more »

Type 1 Diabetes: The Type 1 Diabetes (T1D) Exchange Registry (#106 - 8/17/12)

The Type 1 Diabetes (T1D) Exchange Registry was launched in 2009 to become the largest type 1 diabetes database yet undertaken, funded by the Helmsley Trust Fund.

Posted 9/27/12 (Thu) read more »

Artificial Sweeteners and Diabetes: What is their role in blood sugar and weight management (#105 - 7/18/12)

Artificially sweetened food and beverages have been on the market in the U.S. since the late 1950s and early 1960s, when soda pop, most notably products like Diet Rite cola, Tab cola, and Fresca were produced with cyclamates. Often these products were blended with another artificial sweetener, saccharin.

Posted 9/27/12 (Thu) read more »

American Diabetes Association Scientific Sessions 2012 (#104 - 6/15/12)

I've just returned from the American Diabetes Association Scientific Sessions in Philadelphia where exciting information was presented on topics such as artificial pancreas systems, a new large type 1 diabetes registry, hypoglycemia, new insulins and other drugs in development, prediabetes management, and some large studies on insulin use in cardiovascular disease and insulin and cancer.

Posted 9/27/12 (Thu) read more »

Statins, Cholesterol, and Diabetes (#103 - 3/16/12)

Cardiovascular disease (CVD), a common complication set in adults with type 1 or type 2 diabetes, affects up to two thirds of adult type 1 and type 2 diabetes patients.

Posted 3/20/12 (Tue) read more »

 
This site is TaoPowered™